Disclosures for "A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort"
-
Dr. Hunt has nothing to disclose.
-
Dr. Chu has nothing to disclose.
-
Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sentrex. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex.
-
Ms. West has nothing to disclose.
-
Dr. Uy has nothing to disclose.
-
Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
-
Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
-
Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.